Shares of Incyte Corporation closed the previous trading session at 132.00 up +3.30 2.56% with 1,038,399 shares …
Incyte Corp. has joined the prestigious Standard & Poor's 500, an index of the 500 most widely held stocks on the New York Stock Exchange and Nasdaq. Incyte's addition to the S&P 500 is significant both as a status symbol and as an …
For a hedged play on Incyte (INCY) MarketIntelligenceCenter.com’s patented trade-picking algorithms selected a Feb 16, 2018 $95 covered call for a net debit in the $89.78 area. That is also the break-even stock price for the covered call. …
Incyte Corporation INCY reported third-quarter earnings of 11 cents (including the impact of a change in fair value of acquisition-related contingent consideration and unrealized gain on long term investment). The Zacks Consensus …
This suggests that analysts have very recently bumped up their estimates for INCY, giving the stock a Zacks Earnings ESP of +40.11% heading into earnings season. Why is this Important? A positive reading for the Zacks Earnings ESP …
Apr 6, 2016 07:31 AM Incyte (INCY) Acquires Jakafi Commercialization, Development Rights from Lilly (LLY) Apr 6, 2016 07:30 AM Incyte Acquires Rights from Lilly to Develop and Commercialize Ruxolitinib (Jakafi®) for the Treatment of …
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) (the “Company”) today announced that the Company intends to offer to sell, subject to market and other conditions, 4,945,000 shares of its common stock in an …
... the last earnings report for Incyte Corporation INCY. Shares have added about 3.4% in that time frame, outperforming the market. Will the recent positive trend continue leading up to the stock's next earnings release, or is it due for a …
retaining his “outperform” rating on Incyte stock. The PML infection is caused by the JC virus, often seen in AIDS patients whose immune systems are generally weak. The infection causes further weakness and can lead to life-threatening …